Back
ProShares UltraShort Nasdaq Biotech 10K Form
Sell
20
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
14.35
Seasonality Move:
-11.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIS News And Ratings
See the #1 stock for the next 7 days that we like better than BIS
BIS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
ProShares UltraShort Nasdaq Biotech Earnings Forecast
Key ProShares UltraShort Nasdaq Biotech Financial Ratios
ProShares UltraShort Nasdaq Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | BIS |
| CUSIP: | 74347B |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BIS Technical Analysis vs Fundamental Analysis
Sell
20
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy or a Sell?
-
ProShares UltraShort Nasdaq Biotech stock is rated a Sell
The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.35. The Score for BIS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.